1. Home
  2. ARE vs KRYS Comparison

ARE vs KRYS Comparison

Compare ARE & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alexandria Real Estate Equities Inc.

ARE

Alexandria Real Estate Equities Inc.

HOLD

Current Price

$52.42

Market Cap

9.1B

Sector

Real Estate

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$256.72

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARE
KRYS
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
7.8B
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
ARE
KRYS
Price
$52.42
$256.72
Analyst Decision
Hold
Strong Buy
Analyst Count
11
10
Target Price
$58.78
$297.60
AVG Volume (30 Days)
1.8M
270.3K
Earning Date
04-27-2026
05-18-2026
Dividend Yield
8.73%
N/A
EPS Growth
N/A
128.00
EPS
N/A
6.84
Revenue
$3,026,556,000.00
$389,130,000.00
Revenue This Year
N/A
$40.88
Revenue Next Year
$0.52
$35.16
P/E Ratio
N/A
$38.79
Revenue Growth
N/A
33.94
52 Week Low
$44.10
$123.03
52 Week High
$105.14
$298.30

Technical Indicators

Market Signals
Indicator
ARE
KRYS
Relative Strength Index (RSI) 44.67 44.20
Support Level $49.38 $255.65
Resistance Level $54.86 $293.60
Average True Range (ATR) 1.73 12.37
MACD -0.18 -1.88
Stochastic Oscillator 50.43 16.38

Price Performance

Historical Comparison
ARE
KRYS

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: